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INTRODUCTION 
Drug interaction with food and beverages are known to 
occur exemplified by the well known interaction between 
monoamine oxidase inhibitor and tyramine containing 
food 
1
. Grapefruit ju ice caused the most clinically relevant 
of these interactions as typified in concomitant 
administration of simvastatin with grape juice leading to 
increased risk of statin-induced adverse effects such as 
myopathy 
2
.  
The dissolution and absorption of certain drugs such as 
tetracyclines, flouroquinolones have been reported to be 
marked ly reduced if administered with milk and other 
dairy products. The absorption of aspirin and other 
salicylates have also been shown to be delayed by the 
presence of food while ketoconazole and itraconazole have 
been increased 
3-5
. 
Chlorpropamide is a sulphonylurea and a long acting 
hypoglyceamic agent widely prescribed for patients with 
Type II diabetes mellitus. In non insulin dependent 
diabetes mellitus (NIDDM), diet is usually restricted as a 
supportive in the control of b lood sugar. The concomitant 
administration of food or drink with the oral 
hypoglyceamic agent may affect the rate and extent of 
dissolution and consequently the absorption of the drug 
6
. 
Linking drug doses to daily routines such as meal times 
can improve patient’s compliance; however, the possible 
alteration of the pharmacokinetics of the drug is an issue 
worthy of note. Majority of reported events of therapeutic 
failure in the world may be due to factors that include the 
presence of certain food substances that can reduce the 
dissolution and absorption of drugs in the gastrointestinal 
tract 
7, 8
. 
Chlorpropamide is indicated as an adjunct to  diet and 
exercise to improve glyceamic control in adults. It lowers 
the blood glucose acutely by stimulating the release of 
insulin from the pancreas  thereby exert ing hypoglyceamic 
effect in normal subjects in about an hour and the 
maximum concentration in systemic circulation is  
achieved in 2-3 hours post dose. Chlorpropamide b inds to 
plasma protein and loss of blood sugar control has  been 
reported following concomitant administration of certain  
drugs such as the non steroidal anti-inflammatory drugs 
(NSAID) and sulphonamides. There has been no 
documentary evidence of the pattern of drug level of 
chlorpropamide when taken with certain food eaten in the 
tropics 
9
. The presence or absence of food (state of fill of 
the stomach) determines the rate of emptying of the gastric 
content into the duodenum. Factors that tend to delay 
gastric emptying include fat content of meal, temperature 
and nature of fluid taken i.e. beverages  
10-12
. 
ABSTRACT  
This study compared the disintegration time and dissolution profile of the hypoglyceamic drug product, chlorpropamide 
marketed in Nigeria as Chlorbinese in simulated gastric fluid (SGF), simulated intestinal fluid SIF, food modified gastric 
fluid (FMSGF) and intestinal fluid (FMSIF) as a measure of the effect of dosing condition on in-vivo drug performance. 
Various quality control parameters including weight  uniformity, tablet hardness, disintegration, friability and assay were 
assessed prior the dissolution profile determination. Food containing media were prepared by blending 1.3ml full cream fat 
containing milk and 25mg of soluble starch was added to 500ml and 300ml of SGF and SIF to make FMSGF and FMSIF 
respectively. The in-vivo performance of the drug at the dosing conditions was also determined using 24 healthy volunteers 
with post dosing administration of drug and blood sampling. The titrimetric and spectrophotometric assays gave 99.37% and 
104.12% of chlorpropamide content respectively (P<0.05). No significant differences were observed between the 
disintegration time for FMSGF, SGF, SIF and FMSIF being (5s, 4s ,4s and 6s) respectively at P<0.05. There w as no 
significant difference in the percentage drug release in FMSIF compared with SIF (40% v 35%) similarly there was  no 
difference in the release rate for media simulating dosing conditions in the stomach revealing (28% v 28%) release at 
P<0.05. There was no significant difference in the change in blood glucose level in the volunteers with respect to the dosing 
conditions P<0.05. 
Dosing conditions did not affect the drug release and blood glucose reduction of chlorpropamide tablet. 
Keywords: Chlorpropamide, Food effect, Simulated media, Drug release .Glucose level  
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Food effects are usually not predictable. Generally, the 
presence of food in the gas tric lumen stimulates the flow 
of bile acids which act as surfactants involved in the 
solubilization of fats and lipophilic drugs  
6-9
. 
The study had the objective of establishing whether there 
are differences in the dissolution pattern of chlorpropamide 
tablet in SGF, FMSGF, SIF and FMSIF. The study also 
evaluates the dosing effect on the the performance of 
chlorpropamide. 
MATERIALS AND METHOD 
Materials 
Ethanol, methanol and acetone were products of  Sigma 
Aldrich Chemicals Germany; acetic acid, sodium 
hydroxide, hydrochloric acid, sodium chloride, sodium 
dihydrogen phosphate and potassium phosphate products 
of Kernel Chemicals UK.  
Commercial Tablet 
A pack of 100 by 250mg of chlorpropamide was purchased 
for the study. Details of tablet description are outlined in 
Fig. 1. 
Prepared Reagents  
Study Media 
Simulated Intestinal Fluid  
40g of sodium hydroxide and 34g of monobasic potassium 
phosphate were added to 2L of distilled water and the 
volume made up to 5L mark in a volumetric flask 
13, 14
. 
The resulting pH was 7.32. 
Simulated gastric fluid 
43ml of concentrated hydrochloric acid was added to 2L of 
distilled water in a volumetric flask. This was followed  
with 500ml of 20% sodium chloride solution and the final 
volume made up to 5L 
13, 14 
mark. The resulting pH was 
1.13 
Food modified SGF and SIF 
Food modified SGF and SIF was prepared by adding 
100ml of peak milk and 25mg of soluble starch with 
500ml o f SGF or 300ml of SIF to get food modified SGF 
and SIF respectively 
15
.  
Calibrat ion curve 
Four tablets of chlorpropamide 250mg were crushed into 
fine powder and extracted in 40ml acetone. The drug in 
acetone was filtered and the filtrate was left in a crucible 
and allowed to evaporate at room temperature. 16 mg of 
the recovered drug was dissolved in 40 ml of methanol and 
0.1 N hydrochloric acid used to make up to 50ml to obtain 
the stock solution. 5ml of the prepared stock was diluted to 
100ml with 0.01M hydrochloric acid and this was further 
diluted to give concentrations of 1.6, 3.2, 4.8, 6.4, 8.0, 9.6, 
11.2, 12.8 and 14.4µg/ml. The absorbance of the various 
concentrations was read off from the UV 
spectrophotometer at 232nm.The result was comapred with 
the titrimetric procedure involving the quantitative 
determination of the amount of chlorpropamide released 
from the tablet by the reaction of the excess base in 
solution with perchloric acid.  
 Drug administration and ethical protocols 
The study protocol and the informed consent forms  were 
approved by the Ethical Committee of the University of 
Uyo Health Services, Uyo, Nigeria. The whole study 
which meets the requirements of the declarations of 
Helsinki was conducted in accordance with the Current 
Good Clinical Pract ice (GCP), International Conference 
Harmonizat ion (ICH) as well as Good Laboratory Practice 
(GLP) Guidelines 
16,17
. 
Twenty four young adult healthy volunteers , non smokers, 
aged Mean ± SD (27.4 ± 5.6) years  and body weight Mean 
± SD 72.5 ± 6.3 Kg were recru ited into the study. The 
volunteers were not on concomitant medications and they 
were free from any significant cardiac, hepatic, renal, 
pulmonary, gastrointestinal, neurological or hematological 
disease as reported from a physical examination and 
laboratory tests along with medical history probe 
conducted by a qualified physician four weeks prior the 
commencement of the study. The volunteers were given a 
written informed consent write-up which exp lained the 
nature of the study. All the volunteers were willing to 
participate in the study and were requested to abstain from 
drug and alcohol for three days prior the study. They were 
also requested to fast for at least 10 hours overnight before 
drug administration.  The volunteers were randomly  
selected and grouped into two consisting of 6 males and 6 
females per group. The first group was given 250mg 
chlorpropamide tablet before food. The blood sugar levels 
were read off before the dosing and exactly 3 hours post 
dose. The second group was similarly treated but dos ed 
after ingestion of two sliced bread with 35cl of milk made 
with two heaped teaspoonful Peak powdered milk. The 
volunteers were not restrained from drinking water as 
desired during the study. The study had an open 
randomized crossover design with a 14-day washout 
period between the doses.     
Statistical analysis 
Statistical significance in the values of disintegration and 
dissolution outcome in the different media were evaluated 
through one sample hypothesis  and one tail at α=0.05. 
Significance difference in the mean blood glucose 
reduction within and among the group was evaluated using 
one way ANOVA and chi square. 
RES ULT 
The details of the drug used in the study are laid out in 
Table 1. The physicochemical parameters of the drug are 
expressed in Table 2.  The dissolution and disintegration 
indices of chlorpromazine hydrochloride tablet employed 
in the various simulate media are presented in Table 3.  
The dissolution profile of the drug in the various media  is 
given in Fig 1. The calib ration curve parameters are 
expressed in the equation below. 
Y=2.34x+0.0021; R=0.969 
The resulting pH of the FMSGF and FMSIF are 2.7 and 
7.9 respectively. The outcome of the blood sugar 
measurements are presented in Table 4.  
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Table 1:  The properties of used drugs 
Brand name Chlorpropamide 
Tablet Strength 250mg  
Manufacturer Neimeth Pharmaceuticals  
Country of manufacture Nigeria  
Registration  number 04-7517 
Batch number 00117003 
Manufacturing date 08-2010 
Expiry date 08-2013 
 
Table 2: Disintegration time and Dissolution indices of chlorpropamide tablet in the various media  
Disintegration time and dissolution C 45 in the media  
Disintegration time (min) C45 values (%) from dissolution profile  
SGF SIF FMSGF FMSIF SGF SIF FMSGF FMSIF 
4.0±0.5 4.0±0.6 5.0±0.5 6.0±0.4 28.0   35.0 28.0 40.0 
 
Table 3: The analysis of physicochemical p roperties  of chlorpropamide tablet  
                    Physicochemical p roperties of chlorpropamide  
Friability (%) Crushing Strength (Kg/cm
2
) Weight Uniformity (mg)    Chemical content determination (%w/w) 
Back titrat ion  UV spectrophotometer 
0.079±0.001 2.1±0.6 317.29±0.67 99.37±0.43 104.12±0.67 
 
 
Fig 1: The dissolution profile o f chlorpropamide in the four dissolution media 
Table 4: The statistical analysis of the blood sugar level outcome of the groups of volunteers (n=12) on admin istration of 
chlorpropamide at different dosing conditions 
                                                The  statistical indices of the groups 
                                                                          n(12) 
Groups ∑∆BS ∑∆BS/n SD P 
Group A (+F) 170 14.2 8.6 0.835 
Group A (-F) 145 12.1 9.8 0.409 
Group B (+F) 185 15.4 6.8 0.545 
Group B (-F) 210 17.5 9.5 0.633 
-F= with food ; +F= without food, ∑∆BS=Change in Blood sugar level( mg/dl) 
α=0.05 and significance at P<0.05 
 
DISCUSS ION 
The quality control para meters of the studied drug 
complied with the official specificat ions in BP 1973, this 
gives the confidence of the choice of brand of drug used 
for the study 
18
. UV spectrophotometric determination and 
titrimetric methods were employed for the chemical 
content determination in this work as these are the 
commonly accessible means of quantitative analysis in 
developing countries. The methods were validated and the 
difference in the assay values was  found to be statistically  
insignificant. Routine determinations like this may be 
performed using the available instrumentation method 
such as UV spectrophotometry. The disintegration time 
and dissolution profile of chlorpropamide respectively in 
SIF (4.0s,35%) and SGF (3.5s,28% ) also gives the 
impression of better release pattern  despite the delay in 
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the disintegration time of the dosage form when compared  
to the fed state simulated condition FMSIF (6.0s, 40%) and 
FMSGF (5.0s, 28%). Chlorpropamide a basic compound 
disintegrates to more or less the same extent in  SIF (pH 
7.32) and SGF (pH 1.13). The wide difference in pH did  
not affect the kinetics  of disintegration contrary to 
expectation. This may be due to the formulat ion 
characteristics of the drug i.e. other brands may exh ibit  
difference in disintegration profile. Drugs which occur as 
salt may have common ion effect influencing the 
dissolution profile.  For food to significantly affect the 
dissolution of the drug it is expected that the T70 for the 
food modified media be higher than 45 min 
19
.The SIF and 
SGF revealed unsatisfactory T70 values just as the FMSGF 
and FMSIF hence the values of the food simulated media 
being found to be statistically not different from the fasted 
simulated conditions simply indicates that food did not 
influence the drug disposition. The food modified media 
were designed to simulate the food composition possibly 
available after a typical African diet 
20
. The presence of 
dissolved solutes is typified in the presence of the food 
materials added to the media which are expected to reduce 
the solvent power and invariably the release rate of the 
drug from the drug product 
9
. The one sample statistics 
gave the various means with mean difference of 2.45 and a 
hypothesized mean difference of 0. The confidence limit at 
both one tail and two tail consideration produced F values 
indicating that no statistical difference in the change in 
blood sugar levels of the group with respect to the dosing 
conditions. The single factor ANOVA revealed no 
difference in the mean blood sugar reduction for the 
groups (P 0.05).  
CONCLUS ION 
The dosing conditions did not significantly affect the 
disintegration and dissolution profile of chlorpropamide. 
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